Gufic Biosciences Limited has submitted to the Exchange, the Audited (Standalone and Consolidated) financial results for the Quarter and financial year ended March 31, 2025.
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.2 pts less than Nifty Microcap 250 and 6.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gufic Biosciences has filed its audited financial results (both standalone and consolidated) with the stock exchange for the quarter and full financial year ending March 31, 2025. The announcement is an intimation of submission rather than a detailed results disclosure. Investors will need to refer to the full results document for actual revenue, profit, margin, and balance sheet figures. The audited status indicates the numbers have been verified by the company's statutory auditors.
No immediate price impact from this announcement alone, as it only confirms results have been filed. Investors should review the detailed audited results to assess the company's full-year performance, profit trends, and any auditor remarks.